|
1
|
Zhao D, Liu J, Wang M, Zhang X and Zhou M:
Epidemiology of cardiovascular disease in China: Current features
and implications. Nat Rev Cardiol. 16:203–212. 2019. View Article : Google Scholar
|
|
2
|
Libby P, Buring JE, Badimon L, Hansson GK,
Deanfield J, Bittencourt MS, Tokgözoğlu L and Lewis EF:
Atherosclerosis. Nat Rev Dis Primers. 5:562019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vasan RS and Benjamin EJ: The future of
cardiovascular epidemiology. Circulation. 133:2626–2633. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pan H, Xue C, Auerbach BJ, Fan J, Bashore
AC, Cui J, Yang DY, Trignano SB, Liu W, Shi J, et al: Single-cell
genomics reveals a novel cell state during smooth muscle cell
phenotypic switching and potential therapeutic targets for
atherosclerosis in mouse and human. Circulation. 142:2060–2075.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu S, Kamato D, Little PJ, Nakagawa S,
Pelisek J and Jin ZG: Targeting epigenetics and non-coding RNAs in
atherosclerosis: From mechanisms to therapeutics. Pharmacol Ther.
196:15–43. 2019. View Article : Google Scholar :
|
|
6
|
Simion V, Zhou H, Haemmig S, Pierce JB,
Mendes S, Tesmenitsky Y, Pérez-Cremades D, Lee JF, Chen AF, Ronda
N, et al: A macrophage-specific lncRNA regulates apoptosis and
atherosclerosis by tethering HuR in the nucleus. Nat Commun.
11:61352020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo FX, Wu Q, Li P, Zheng L, Ye S, Dai XY,
Kang CM, Lu JB, Xu BM, Xu YJ, et al: The role of the
LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of
autophagy flux and inflammation through mTOR-dependent signaling.
Cell Death Differ. 26:1670–1687. 2019. View Article : Google Scholar :
|
|
8
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis, and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014. View Article : Google Scholar :
|
|
9
|
Mahmoud AD, Ballantyne MD, Miscianinov V,
Pinel K, Hung J, Scanlon JP, Iyinikkel J, Kaczynski J, Tavares AS,
Bradshaw AC, et al: The human-specific and smooth muscle
cell-enriched LncRNA SMILR promotes proliferation by regulating
mitotic CENPF mRNA and drives cell-cycle progression which can be
targeted to limit vascular remodeling. Circ Res. 125:535–551. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong XH, Lu ZF, Kang CM, Li XH, Haworth
KE, Ma X, Lu JB, Liu XH, Fang FC, Wang CS, et al: The long
noncoding RNA RP11-728F11.4 promotes atherosclerosis. Arterioscler
Thromb Vasc Biol. 41:1191–1204. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu YW, Guo FX, Xu YJ, Li P, Lu ZF, McVey
DG, Zheng L, Wang Q, Ye JH, Kang CM, et al: Long noncoding RNA
NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding
protein NEXN. J Clin Invest. 129:1115–1128. 2019. View Article : Google Scholar :
|
|
12
|
Bai HL, Lu ZF, Zhao JJ, Ma X, Li XH, Xu H,
Wu SG, Kang CM, Lu JB, Xu YJ, et al: Microarray profiling analysis
and validation of novel long noncoding RNAs and mRNAs as potential
biomarkers and their functions in atherosclerosis. Physiol
Genomics. 51:644–656. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang CM, Bai HL, Li XH, Huang RY, Zhao JJ,
Dai XY, Zheng L, Qiu YR, Hu YW and Wang Q: The binding of lncRNA
RP11-732M18.3 with 143-3 β/α accelerates p21 degradation and
promotes glioma growth. EBioMedicine. 45:58–69. 2019. View Article : Google Scholar :
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Dubland JA, Allahverdian S, Asonye
E, Sahin B, Jaw JE, Sin DD, Seidman MA, Leeper NJ and Francis GA:
Smooth muscle cells contribute the majority of foam cells in ApoE
(Apolipoprotein E)-deficient mouse atherosclerosis. Arterioscler
Thromb Vasc Biol. 39:876–887. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guizani I, Zidi W, Zayani Y, Boudiche S,
Hadj-Taieb S, Sanhaji H, Zaroui A, Mechmeche R, Mourali MS, Feki M
and Allal-Elasmi M: Matrix metalloproteinase-3 predicts clinical
cardiovascular outcomes in patients with coronary artery disease: A
5 years cohort study. Mol Biol Rep. 46:4699–4707. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Galis ZS, Sukhova GK, Lark MW and Libby P:
Increased expression of matrix metalloproteinases and matrix
degrading activity in vulnerable regions of human atherosclerotic
plaques. J Clin Invest. 94:2493–2503. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Johnson JL, Dwivedi A, Somerville M,
George SJ and Newby AC: Matrix metalloproteinase (MMP)-3 activates
MMP-9 mediated vascular smooth muscle cell migration and neointima
formation in mice. Arterioscler Thromb Vasc Biol. 31:e35–e44. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du X, Patel A, Anderson CS, Dong J and Ma
C: Epidemiology of cardiovascular disease in China and
opportunities for improvement: JACC international. J Am Coll
Cardiol. 73:3135–3147. 2019. View Article : Google Scholar
|
|
21
|
Libby P, Bornfeldt KE and Tall AR:
Atherosclerosis: Successes, surprises, and future challenges. Circ
Res. 118:531–534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Allahverdian S, Chaabane C, Boukais K,
Francis GA and Bochaton-Piallat ML: Smooth muscle cell fate and
plasticity in atherosclerosis. Cardiovasc Res. 114:540–550. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Cui X, Wang C and Zhao S: LncRNA
HCG11 regulates proliferation and apoptosis of vascular smooth
muscle cell through targeting miR-144-3p/FOXF1 axis in
atherosclerosis. Biol Res. 53:442020. View Article : Google Scholar :
|
|
24
|
Tang R, Mei X, Wang YC, Cui XB, Zhang G,
Li W and Chen SY: LncRNA GAS5 regulates vascular smooth muscle cell
cycle arrest and apoptosis via p53 pathway. Biochim Biophys Acta
Mol Basis Dis. 1865:2516–2525. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Z, Zou G, Chen X, Lu W, Liu J, Zhai
S and Qiao G: Knockdown of lncRNA PVT1 inhibits vascular smooth
muscle cell apoptosis and extracellular matrix disruption in a
murine abdominal aortic aneurysm model. Mol Cells. 42:218–227.
2019.PubMed/NCBI
|
|
26
|
Subramaniam N, Nair R and Marsden PA:
Epigenetic regulation of the vascular endothelium by angiogenic
LncRNAs. Front Genet. 12:6683132021. View Article : Google Scholar :
|
|
27
|
Wang YQ, Xu ZM, Wang XL, Zheng JK, Du Q,
Yang JX and Zhang HC: LncRNA FOXC2-AS1 regulated proliferation and
apoptosis of vascular smooth muscle cell through targeting
miR-1253/FOXF1 axis in atherosclerosis. Eur Rev Med Pharmacol Sci.
24:3302–3314. 2020.
|
|
28
|
Kumar MM and Goyal R: LncRNA as a
therapeutic target for angiogenesis. Curr Top Med Chem.
17:1750–1757. 2017. View Article : Google Scholar :
|
|
29
|
Yu AM, Choi YH and Tu MJ: RNA drugs and
RNA targets for small molecules: Principles, progress and
challenges. Pharmacol Rev. 72:862–898. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johnson JL: Metalloproteinases in
atherosclerosis. Eur J Pharmacol. 816:93–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Monaco C, Gregan SM, Navin TJ, Foxwell BM,
Davies AH and Feldmann M: Toll-like receptor-2 mediates
inflammation and matrix degradation in human atherosclerosis.
Circulation. 120:2462–2469. 2009. View Article : Google Scholar
|
|
32
|
Hu W, Wei R, Wang L, Lu J, Liu H and Zhang
W: Correlations of MMP-1, MMP-3, and MMP-12 with the degree of
atherosclerosis, plaque stability and cardiovascular and
cerebrovascular events. Exp Ther Med. 15:1994–1998. 2018.PubMed/NCBI
|
|
33
|
Ma L and Zhang L, Wang B, Wei J, Liu J and
Zhang L: Berberine inhibits Chlamydia pneumoniae infection-induced
vascular smooth muscle cell migration through downregulating MMP3
and MMP9 via PI3K. Eur J Pharmacol. 755:102–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Seifi M, Fallah S and Firoozrai M:
Influence of genetic polymorphism in matrix metalloproteinase-3 on
extent of coronary atherosclerosis and risk of coronary artery
stenosis. Arch Med Res. 40:600–604. 2009. View Article : Google Scholar
|
|
35
|
Kraen M, Frantz S, Nihlén U, Engström G,
Löfdahl CG, Wollmer P and Dencker M: Matrix metalloproteinases in
COPD and atherosclerosis with emphasis on the effects of smoking.
PLoS One. 14:e02119872019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kaplan RC, Smith NL, Zucker S, Heckbert
SR, Rice K and Psaty BM: Matrix metalloproteinase-3 (MMP3) and MMP9
genes and risk of myocardial infarction, ischemic stroke, and
hemorrhagic stroke. Atherosclerosis. 201:130–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alexander MR, Moehle CW, Johnson JL, Yang
Z, Lee JK, Jackson CL and Owens GK: Genetic inactivation of IL-1
signaling enhances atherosclerotic plaque instability and reduces
outward vessel remodeling in advanced atherosclerosis in mice. J
Clin Invest. 122:70–79. 2012. View Article : Google Scholar :
|
